Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

Sussing out a new alliance
March 2019
SHARING OPTIONS:

LAUSANNE, Switzerland & SHANGHAI—AC Immune SA and WuXi Biologics teamed up in recent months under the umbrella of an exclusive strategic collaboration focused on the discovery, development and manufacturing of biologics. The companies inked a memorandum of understanding for a preferred partnership that grants AC Immune access to WuXi Biologics’ platforms in manufacturing and supplying traditional and novel New Biological Entities against CNS disorders. WuXi will become a preferred partner for AC Immune for bioprocess development and manufacturing. The agreement also covers the potential use of AC Immune’s platform to treat non-CNS diseases, and the potential for WuXi Vaccines, the vaccine arm of WuXi Biologics, to apply AC Immune’s vaccine portfolio in China.

Back



PAGE UTILITIES


CONTACT US
DDNEWS
1000 N West Street, Suite 1200,
Wilmington, Delaware, 19801
Ph: 888-781-0328 |  Fax: 705-528-0270
 
© Copyright 2020 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.